209 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Verastem Oncology Funding History

Since Verastem Oncology was founded in 2010, it has participated in 13 rounds of funding. In total Verastem Oncology has raised $531.7M. Verastem Oncology's last funding round was on Jan 2025 for a total of $7.5M.

Verastem Oncology Funding Rounds

Unlock 10 more funding rounds →

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Post-IPO Equity
Jan 2025
$7.5M
1
Oberland Capital Management
Post-IPO Debt
Jan 2025
$150M
1
Oberland Capital Management
Post-IPO Equity
Jun 2023
$85M
__
Private Placement
Jan 2023
$30M
__
Private Placement
Feb 2020
$100M
__

Total Funding: $531.7M

Verastem Oncology Investors

Unlock 4 more investors →

INVESTOR

ROUND

FUNDING DATE

Oberland Capital Management
Post-IPO Equity, Post-IPO Debt
Jan 2025
Hercules Technology Growth Capital
Post-IPO Debt
Mar 2017
Advanced Technology Ventures
Series B
Jul 2011
Longwood Founders Fund
Series B, Series A
Jul 2011, Nov 2010
Bessemer Venture Partners
Series B, Series A
Jul 2011, Nov 2010

Total Investors: 7

Verastem Oncology has 7 investors, including Oberland Capital Management, Hercules Technology Growth Capital and Advanced Technology Ventures. The latest investment occurred in Jan 2025.